Dr. Lawrence E. Garbo, MD

Claim this profile

New York Oncology Hematology, P.C.

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1

Lung Cancer

Lawrence E. Garbo, MD has run 1 trial for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive
2

Non-Small Cell Lung Cancer

Lawrence E. Garbo, MD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive

Affiliated Hospitals

Image of trial facility.

New York Oncology Hematology, P.C.

Clinical Trials Lawrence E. Garbo, MD is currently running

More about Lawrence E. Garbo, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Lawrence E. Garbo, MD has experience with

  • Osimertinib
  • Quaratusugene Ozeplasmid
  • CTX-009
  • Paclitaxel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Lawrence E. Garbo, MD specialize in?

Is Lawrence E. Garbo, MD currently recruiting for clinical trials?

Are there any treatments that Lawrence E. Garbo, MD has studied deeply?

What is the best way to schedule an appointment with Lawrence E. Garbo, MD?

What is the office address of Lawrence E. Garbo, MD?

Is there any support for travel costs?